Catalyst Wire Dossier Catalyst Wire Dossier

Anti-CHIKV Hyperimmune Intravenous Immunoglobulins

Chikungunya virus-specific hyperimmune intravenous immunoglobulin
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-CHIKV Hyperimmune Intravenous Immunoglobulins, covering 2014-11-03 to 2014-11-03. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Evaluation of Anti-CHIKV Hyperimmune Intravenous Immunoglobulins [Phase 1, Phase 2]

See pricing